Alkermes plc.
ALKSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Alkermes plc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
No 13F rows are listed for Alkermes plc.
- 8 rows left out: they repeat the same share count and value quarter after quarter, which a market value cannot do.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Alkermes plc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-29 · Parisi Samuel Joseph: Larger than 23 of the 25 other insider sales of Ordinary Shares on file. SEC filing
- 2026-02-02 · Cooke Shane: Larger than all 25 other insider sales of Ordinary Shares on file. SEC filing
- 2026-02-02 · Cooke Shane: Larger than 24 of the 25 other insider sales of Ordinary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-12 | Wright Christopher I · Director | Ordinary Shares | S — Open market or private sale | −2,000 | 45.10 | SEC filing |
| 2026-06-04 | Gaffin David Joseph · EVP, CLO, Alkermes, Inc. | Ordinary Shares | S — Open market or private sale | −2,034 | 43.05 | SEC filing |
| 2026-06-01 | Hopkinson Craig C. · EVP R&D, Chief Medical Officer | Ordinary Shares | S — Open market or private sale | −9,000 | 41.67 | SEC filing |
| 2026-05-29 | Parisi Samuel Joseph · VP, Finance (Interim PAO) | Ordinary Shares | S — Open market or private sale | −16,217 | 42.36 | SEC filing |
| 2026-05-04 | Gaffin David Joseph · EVP, CLO, Alkermes, Inc. | Ordinary Shares | S — Open market or private sale | −2,034 | 33.20 | SEC filing |
| 2026-05-01 | Hopkinson Craig C. · EVP R&D, Chief Medical Officer | Ordinary Shares | S — Open market or private sale | −9,000 | 33.40 | SEC filing |
| 2026-04-06 | Gaffin David Joseph · EVP, CLO, Alkermes, Inc. | Ordinary Shares | S — Open market or private sale | −2,034 | 34.57 | SEC filing |
| 2026-04-01 | Hopkinson Craig C. · EVP R&D, Chief Medical Officer | Ordinary Shares | S — Open market or private sale | −9,000 | 35.51 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-01 | Hopkinson Craig C. · EVP R&D, Chief Medical Officer | Ordinary Shares | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-06-01 | Hopkinson Craig C. · EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
| 2026-05-29 | Parisi Samuel Joseph · VP, Finance (Interim PAO) | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −3,392 | SEC filing |
| 2026-05-29 | Parisi Samuel Joseph · VP, Finance (Interim PAO) | Ordinary Shares | M — Exercise or conversion of derivative security | +12,825 | SEC filing |
| 2026-05-29 | Parisi Samuel Joseph · VP, Finance (Interim PAO) | Employee Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −12,825 | SEC filing |
| 2026-05-29 | Parisi Samuel Joseph · VP, Finance (Interim PAO) | Ordinary Shares | M — Exercise or conversion of derivative security | +3,392 | SEC filing |
| 2026-05-21 | MCKEON BRIAN P · Director | Ordinary Shares | M — Exercise or conversion of derivative security | +6,142 | SEC filing |
| 2026-05-21 | GAYNOR RICHARD · Director | Restricted Stock Unit Award | M — Exercise or conversion of derivative security | −6,142 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.